ISIN | CH0287280843 |
---|---|
Valor Number | 28728084 |
Bloomberg Global ID | |
Fund Name | Bellevue Healthcare Strategy I2 |
Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fund Provider | Bellevue Asset Management AG |
Representative in Switzerland | |
Distributor(s) |
Zürcher Kantonalbank Zürich Phone: +41 44 293 93 93 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | Special conditions apply to the issue of units |
Redemption Condition | Special conditions apply to the redemption of units |
Investment Strategy *** | N/A |
Peculiarities |
Current Price * | 167.11 CHF | 23.09.2024 |
---|---|---|
Previous Price * | 167.81 CHF | 20.09.2024 |
52 Week High * | 171.35 CHF | 30.08.2024 |
52 Week Low * | 148.48 CHF | 27.10.2023 |
NAV * | 167.11 CHF | 23.09.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 207,428,362 | |
Unit/Share Assets *** | 57,613,105 | |
Trading Information SIX |
YTD Performance | +10.05% |
29.12.2023 - 23.09.2024
29.12.2023 23.09.2024 |
---|---|---|
1 month | -1.54% |
23.08.2024 - 23.09.2024
23.08.2024 23.09.2024 |
3 months | +0.07% |
24.06.2024 - 23.09.2024
24.06.2024 23.09.2024 |
6 months | +1.16% |
25.03.2024 - 23.09.2024
25.03.2024 23.09.2024 |
1 year | +5.23% |
25.09.2023 - 23.09.2024
25.09.2023 23.09.2024 |
2 years | +8.97% |
23.09.2022 - 23.09.2024
23.09.2022 23.09.2024 |
3 years | -15.10% |
23.09.2021 - 23.09.2024
23.09.2021 23.09.2024 |
5 years | +27.10% |
23.09.2019 - 23.09.2024
23.09.2019 23.09.2024 |
Equity Participation Rate in % | 96.94 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 1.0191 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 23.09.2024 |
Vertex Pharmaceuticals Inc | 3.35% | |
---|---|---|
Regeneron Pharmaceuticals Inc | 3.17% | |
UnitedHealth Group Inc | 3.13% | |
Insulet Corp | 3.09% | |
McKesson Corp | 3.09% | |
HCA Healthcare Inc | 3.07% | |
Eli Lilly and Co | 3.04% | |
Boston Scientific Corp | 2.99% | |
IQVIA Holdings Inc | 2.94% | |
UCB SA | 2.91% | |
Last data update | 31.07.2024 |
TER | 0.61% |
---|---|
TER date | 29.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 31.08.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |